Dozens of people sue GLP-1 drug companies over alleged vision loss
More than 90 lawsuits against GLP-1 companies claim rare eye condition resulted from diabetes and weight loss drugs
Originally published by Al Jazeera. Summary and curation by DutyStation News.


